Literature DB >> 28357811

Use of fluorine-18 sodium fluoride for the diagnosis of transthyretin cardiac amyloidosis: The birth of a new technique.

Cesia Gallegos1, Edward J Miller2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28357811     DOI: 10.1007/s12350-017-0847-6

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   5.952


× No keyword cloud information.
  9 in total

Review 1.  AL (Light-Chain) Cardiac Amyloidosis: A Review of Diagnosis and Therapy.

Authors:  Rodney H Falk; Kevin M Alexander; Ronglih Liao; Sharmila Dorbala
Journal:  J Am Coll Cardiol       Date:  2016-09-20       Impact factor: 24.094

2.  Standardization of 99mTechnetium pyrophosphate imaging methodology to diagnose TTR cardiac amyloidosis.

Authors:  Sabahat Bokhari; Rachelle Morgenstern; Richard Weinberg; Mona Kinkhabwala; Demetrios Panagiotou; Adam Castano; Albert DeLuca; Andrew Kontak; Zhezhen Jin; Mathew S Maurer
Journal:  J Nucl Cardiol       Date:  2016-08-31       Impact factor: 5.952

3.  18Fluorine sodium fluoride positron emission tomography, a potential biomarker of transthyretin cardiac amyloidosis.

Authors:  Rachelle Morgenstern; Randy Yeh; Adam Castano; Mathew S Maurer; Sabahat Bokhari
Journal:  J Nucl Cardiol       Date:  2017-02-07       Impact factor: 5.952

4.  Does the etiology of cardiac amyloidosis determine the myocardial uptake of [18F]-NaF PET/CT?

Authors:  Christian Gagliardi; Elena Tabacchi; Rachele Bonfiglioli; Stefania Diodato; Cristina Nanni; Pierluigi Guidalotti; Massimiliano Lorenzini; Filippo Lodi; Agnese Milandri; Claudio Rapezzi; Stefano Fanti
Journal:  J Nucl Cardiol       Date:  2016-03-14       Impact factor: 5.952

5.  [18F]-NaF PET/CT imaging in cardiac amyloidosis.

Authors:  Axel Van Der Gucht; Arnault Galat; Jean Rosso; Aziz Guellich; Jérôme Garot; Diane Bodez; Violaine Plante-Bordeneuve; Luc Hittinger; Jean-Luc Dubois-Randé; Eva Evangelista; Myriam Sasanelli; Julia Chalaye; Michel Meignan; Emmanuel Itti; Thibaud Damy
Journal:  J Nucl Cardiol       Date:  2015-09-24       Impact factor: 5.952

6.  (99m)Tc-pyrophosphate scintigraphy for differentiating light-chain cardiac amyloidosis from the transthyretin-related familial and senile cardiac amyloidoses.

Authors:  Sabahat Bokhari; Adam Castaño; Ted Pozniakoff; Susan Deslisle; Farhana Latif; Mathew S Maurer
Journal:  Circ Cardiovasc Imaging       Date:  2013-02-11       Impact factor: 7.792

Review 7.  Transthyretin (TTR) cardiac amyloidosis.

Authors:  Frederick L Ruberg; John L Berk
Journal:  Circulation       Date:  2012-09-04       Impact factor: 29.690

8.  18F-Sodium Fluoride PET/MR for the Assessment of Cardiac Amyloidosis.

Authors:  Maria Giovanna Trivieri; Marc R Dweck; Ronan Abgral; Philip M Robson; Nicolas A Karakatsanis; Anuradha Lala; Johanna Contreras; Gagan Sahni; Radha Gopalan; Peter Gorevic; Valentin Fuster; Jagat Narula; Zahi A Fayad
Journal:  J Am Coll Cardiol       Date:  2016-12-20       Impact factor: 24.094

9.  Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis.

Authors:  Julian D Gillmore; Mathew S Maurer; Rodney H Falk; Giampaolo Merlini; Thibaud Damy; Angela Dispenzieri; Ashutosh D Wechalekar; John L Berk; Candida C Quarta; Martha Grogan; Helen J Lachmann; Sabahat Bokhari; Adam Castano; Sharmila Dorbala; Geoff B Johnson; Andor W J M Glaudemans; Tamer Rezk; Marianna Fontana; Giovanni Palladini; Paolo Milani; Pierluigi L Guidalotti; Katarina Flatman; Thirusha Lane; Frederick W Vonberg; Carol J Whelan; James C Moon; Frederick L Ruberg; Edward J Miller; David F Hutt; Bouke P Hazenberg; Claudio Rapezzi; Philip N Hawkins
Journal:  Circulation       Date:  2016-04-22       Impact factor: 29.690

  9 in total
  1 in total

1.  Examining the sensitivity of 18F-NaF PET for the imaging of cardiac amyloidosis.

Authors:  Patrick Martineau; Vincent Finnerty; Geneviève Giraldeau; Sébastien Authier; Francois Harel; Matthieu Pelletier-Galarneau
Journal:  J Nucl Cardiol       Date:  2019-03-04       Impact factor: 5.952

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.